Arteris (AIP) to Release Quarterly Earnings on Thursday

Arteris (NASDAQ:AIP) will likely be posting its Q4 2025 results after the market closes on Thursday, February 12th. Analysts expect Arteris to post earnings of ($0.08) per share and revenue of $18.55 million for the quarter. Parties may review the information on the company’s upcoming Q4 2025 earning report for the latest details on the call scheduled for Thursday, February 12, 2026 at 4:30 PM ET.

Arteris (NASDAQ:AIP) last announced its quarterly earnings data on Tuesday, November 4th. The company reported ($0.09) earnings per share for the quarter, beating the consensus estimate of ($0.11) by $0.02. The firm had revenue of $17.41 million during the quarter, compared to the consensus estimate of $17.00 million. On average, analysts expect Arteris to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Arteris Stock Down 2.3%

NASDAQ:AIP opened at $14.19 on Thursday. The company has a market cap of $619.82 million, a PE ratio of -17.10 and a beta of 1.47. The business’s 50 day moving average is $16.30 and its two-hundred day moving average is $13.03. Arteris has a 52 week low of $5.46 and a 52 week high of $19.85.

Insider Activity

In other Arteris news, VP Paul L. Alpern sold 5,000 shares of Arteris stock in a transaction on Monday, February 2nd. The stock was sold at an average price of $15.48, for a total transaction of $77,400.00. Following the sale, the vice president owned 57,650 shares of the company’s stock, valued at $892,422. The trade was a 7.98% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Bayview Legacy, Llc sold 17,884 shares of the stock in a transaction on Thursday, January 15th. The stock was sold at an average price of $17.84, for a total value of $319,050.56. Following the completion of the transaction, the insider directly owned 9,399,071 shares of the company’s stock, valued at approximately $167,679,426.64. The trade was a 0.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 589,072 shares of company stock worth $10,005,603 over the last ninety days. 29.10% of the stock is owned by company insiders.

Institutional Trading of Arteris

A number of hedge funds and other institutional investors have recently made changes to their positions in AIP. AQR Capital Management LLC acquired a new position in Arteris in the first quarter worth approximately $1,621,000. Algert Global LLC acquired a new stake in shares of Arteris during the 3rd quarter valued at $2,250,000. Arrowstreet Capital Limited Partnership boosted its stake in shares of Arteris by 8.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 320,332 shares of the company’s stock worth $3,053,000 after acquiring an additional 25,448 shares in the last quarter. Westerly Capital Management LLC grew its holdings in shares of Arteris by 14.5% in the 2nd quarter. Westerly Capital Management LLC now owns 680,000 shares of the company’s stock worth $6,480,000 after acquiring an additional 85,950 shares during the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Arteris by 4.8% in the 2nd quarter. Geode Capital Management LLC now owns 652,754 shares of the company’s stock worth $6,222,000 after acquiring an additional 30,018 shares during the last quarter. 64.36% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on AIP. Rosenblatt Securities restated a “buy” rating and set a $20.00 price objective on shares of Arteris in a research note on Monday, December 15th. TD Cowen restated a “buy” rating on shares of Arteris in a research report on Wednesday, November 5th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arteris in a research report on Wednesday, January 21st. Finally, Jefferies Financial Group upgraded shares of Arteris to a “hold” rating in a research note on Tuesday, October 28th. Three investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $17.50.

Arteris Company Profile

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.